Are Formulary Decision Makers Data Needs Being Met for Specialty Drugs?

This study targeted pharmacists and physicians involved with formulary decision making in order to assess the level of satisfaction of specialty drug formulary decision makers with regards to the strength of current available data sources and unmet needs regarding clinical, economic, and unpublished evidence. See more here. (Source: JMCP Volume 22 Issue (4), April 2016)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020
Leveraging Technology to Reduce Costs in Clinical Trials 06/30/2019
The Growing Influence of the Institute of Clinical and… 11/21/2019